Anders Edvell
Director/Board Member chez RLS GLOBAL AB (PUBL)
Profil
Anders Edvell is currently the Chief Executive Officer at Immedica Pharma AB and an Independent Director at Rls Global AB.
He is also a Director at LFF Service AB and a former Country Manager at Swedish Orphan Biovitrum International AB.
Prior to his current positions, he was the Chief Executive Officer at Unimedic AB and the VP, Head-Specialty Care & Partner Products at Swedish Orphan Biovitrum AB.
Edvell holds an MBA and a doctorate from Stockholm School of Economics, an undergraduate degree from the University of Basel, and an undergraduate degree from Scandinavian International Management Institute.
Postes actifs de Anders Edvell
| Sociétés | Poste | Début |
|---|---|---|
| RLS GLOBAL AB (PUBL) | Director/Board Member | 01/01/2023 |
| LFF Service AB | Director/Board Member | - |
Swedish Orphan Biovitrum International AB
 Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Chief Executive Officer | 01/08/2018 |
Anciens postes connus de Anders Edvell
| Sociétés | Poste | Fin |
|---|---|---|
Unimedic AB
 Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Chief Executive Officer | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Formation de Anders Edvell
| Stockholm School of Economics | Doctorate Degree |
| University of Basel | Undergraduate Degree |
| Scandinavian International Management Institute | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| RLS GLOBAL AB (PUBL) | Health Technology |
| Entreprise privées | 4 |
|---|---|
Unimedic AB
Unimedic AB Pharmaceuticals: MajorHealth Technology Unimedic AB manufactures and sells pharmaceuticals and chemical engineering products. It offers a wide range of licensed and unlicensed medicines and extemporaneous pharmaceuticals as well as non-prescription heath care products and pharmaceutical aids. The company was founded by Nils Ivrell, Lennart Leyoberg, and Kenth-Olov Norman in 1992 and is headquartered in Matfors, Sweden. | Health Technology |
| LFF Service AB | |
Swedish Orphan Biovitrum International AB
Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Health Technology |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Distribution Services |
